MFN2 protein in astrocytes linked to depressive-like behaviors
High MFN2 expression in astrocytes contributes to neuronal hyperexcitability and depressive-like behaviors.
MFN2-associated astrocyte dysfunction contributes to neuronal hyperexcitability and depressive-like behaviors. This dysfunction involves excessive mitochondrial fusion and impaired mitophagy.
Researchers used SMART-seq profiling on hippocampal astrocytes from chronic social defeat stress (CSDS) mice. They found MFN2 up-regulation and astrocyte loss.
Elevated MFN2 expression was detected in plasma, postmortem brain tissue, and iPSC-derived astrocytes from patients with MDD. Astrocytes are cells that interact with neurons.
Mitophagy is the process of removing mitochondria. MFN2 is a protein associated with mitochondrial dynamics.
Astrocyte-specific knockdown of MFN2 restored mitochondrial morphology and mitophagy. This process preserved astrocyte viability and alleviated depressive-like behaviors.
The findings show that the β-arrestin2-STAT1 pathway acts as an upstream regulatory mechanism. This work highlights a potential therapeutic target that addresses astrocyte pathology.
Key facts
- MFN2 up-regulation in astrocytes is accompanied by excessive mitochondrial fusion and impaired mitophagy.
- Knocking down MFN2 in astrocytes reduced extracellular glutamate accumulation and prevented neuronal hyperexcitability.
- β-arrestin2 deficiency reduces STAT1 stability, which releases its transcriptional repression on MFN2.